Clik here to view.
ITC opens probe of China’s BMC Medical in patent war with ResMed
The U.S. International Trade Commission yesterday opened a probe into BMC Medical‘s importation of sleep apnea devices, as the long-running patent infringement war between the Chinese company and...
View ArticleClik here to view.
Biotelemetry closes $16m VirtualScopics buy
BioTelemetry (NSDQ:BEAT) said yesterday that it closed its $15.5 million acquisition of clinical trial imaging provider VirtualScopics (NSDQ:VSCP), approximately 6 weeks after the deal was 1st...
View ArticleClik here to view.
Wright Medical lands $395m debt placement
Wright Medical (NSDQ:WMGI) today said it raised $395 million in a private placement of debt with a syndicate of institutional investors. The offering, of 2.25% convertible senior notes due in 2021, is...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 13, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Humacyte launches pivotal trial for lab-grown blood vessel
Humacyte is launching a Phase III study of its lab-grown blood vessel Humacyl in 350 patients with end-stage renal disease who are on hemodialysis and don’t qualify for a standard surgical treatment,...
View ArticleClik here to view.
Exthera Medical closes $12 million Series A for Seraph blood infection filter
Martinez, Calif.-based Exthera Medical said it raised a $12 million Series A round following positive tests of its CE-Marked Seraph blood filter in animal studies. The company announced in January...
View ArticleClik here to view.
NeoChord wins FDA nod for mitral valve repair trial
NeoChord said it won an investigational device exemption from the FDA for a clinical trial of its mitral valve repair technology. St. Louis Park, Minn.-based NeoChord said the 20-site study is a...
View ArticleClik here to view.
FDA releases draft guidance on 3D-printed medical devices
The FDA this week issued draft guidance intended to ensure the safe and reliable use of 3D printing for medical devices, a 25-page document that covers everything from design and manufacturing to...
View ArticleClik here to view.
Sensus Healthcare scales back planned IPO
Sensus Healthcare last week said it plans to scale back its planned initial public offering, after tabling the flotation earlier this year. Boca Raton, Fla.-based Sensus makes the SRT-100 and SRT-100...
View ArticleClik here to view.
Report: ConvaTec preps $1B IPO
ConvaTec is reportedly seeking investment banks to hire underwriters for an initial public offering that could raise more than $1 billion. The Luxembourg-based medical device company, which makes...
View ArticleClik here to view.
Impulse Dynamics raises $30m for Optimizer IVs implantable heart failure device
Impulse Dynamics said last week that it raised $30 million for its Optimizer IVs implantable heart failure device, led by the Hong Kong investment fund of real estate developer Peter Lee Ka Kit....
View ArticleClik here to view.
Allergan’s Oculeve on track for FDA submission this year
Allergan (NYSE:AGN) said today that it’s on track for an FDA submission this year for the Oculeve nasal neurostimulation device for dry eye it bought last year. Oculeve is a hand-held device designed...
View ArticleClik here to view.
Turning 40, St. Jude Medical launches Trifecta GT in US
St. Jude Medical (NYSE:STJ) today marked its 40th birthday with the U.S. launch of its Trifecta GT replacement aortic valve after winning FDA approval last month. The Little Canada, Minn.-based medical...
View ArticleClik here to view.
Otsuka gets in on ReCor Medical’s Paradise renal denervation device
ReCor Medical said it landed a strategic investment from Japanese conglomerate Otsuka Pharmaceutical (TYO:4578) that will bring to Asia its Paradise renal denervation device for treating hypertension....
View ArticleClik here to view.
FDA lifts recall on Custom Ultrasonics endoscope reprocessors
Custom Ultrasonics said today that the FDA lifted the recall on its endoscope reprocessors while the company looks to correct the violations that prompted the recall. Ivyland, Pa.-based Custom...
View ArticleClik here to view.
Biom’Up announced it has received FDA clearance for the HEMOBLASTTM Bellows...
The prospective, randomized, controlled, multi-center clinical investigation evaluates the safety and efficacy of HEMOBLASTTM Bellows, the company’s novel hemostat, in cardiothoracic, abdominal, and...
View ArticleClik here to view.
Luminex pays $83m for Nanosphere
Luminex (NSDQ:LMNX) agreed to pay a total of $83 million to acquire Nanosphere (NSDQ:NSPH) and its Verigene molecular diagnostics technology. The $1.35-per-share, all-cash deal consists of a 15-day...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 16, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
BioVentrix touts 1st-in-human procedure for Revivent device
BioVentrix said it successfully implanted its micro-anchor Revivent device into a 64-year-old female patient suffering from heart failure symptoms following a heart attack. The first-in-human test...
View ArticleClik here to view.
India updates patent policies for medical devices and drugs
India took a step toward modernizing its approach toward intellectual property, encouraging news for both the medical device and drug development industries. India had announced a new intellectual...
View Article